Literature DB >> 8427178

Persistence of coronary vasodilator responsivity after cardiac transplantation.

M J Senneff1, J Hartman, B E Sobel, E M Geltman, S R Bergmann.   

Abstract

Accelerated graft atherosclerosis is a major cause of death after cardiac transplantation. Although its detection currently requires surveillance angiography, loss of vasodilator responsivity may precede obstructive lesions and be detectable by noninvasive assessment of myocardial perfusion. Thirty-five allograft recipients were studied an average of 31 +/- 19 (mean +/- SD) months after transplantation. All were free from angiographically definable macrovascular obstructive coronary artery lesions. Nutritive myocardial perfusion at rest, estimated in absolute terms by positron emission tomography with oxygen-15 water averaged 1.63 +/- 0.51 ml/g/min in patients and was greater than that in 26 healthy volunteers (1.17 +/- 0.33 ml/g/min, p < 0.001). The increase correlated with increased cardiac work at rest in transplant recipients with arterial hypertension and tachycardia. Peak myocardial perfusion induced by intravenous administration of dipyridamole was normal in the transplant recipients (3.49 +/- 1.70 ml/g/min compared with 3.60 +/- 1.41 ml/g/min in volunteers). Because of the high flow at rest, myocardial perfusion reserve (the ratio of hyperemic flow to flow at rest) was diminished (2.3 +/- 1.2 compared with 3.3 +/- 1.5 in volunteers, p < 0.005). These results indicate that the responsivity to vasodilator stimulation is well preserved in transplant recipients devoid of macroscopic coronary arterial lesions obviating detection of early vascular dysfunction in individual subjects. Positron emission tomography may be useful, however, in quantifying the magnitude of the increase in flow at rest secondary to increased cardiac work--a potentially remedial cause of accelerated coronary vascular disease induced by high shear force activation of platelets in the coronary bed, and in detecting impaired perfusion once macrovascular vascular disease is extant.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427178     DOI: 10.1016/0002-9149(93)90801-i

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Tracer kinetic modeling in nuclear cardiology.

Authors:  T R DeGrado; S R Bergmann; C K Ng; D M Raffel
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients.

Authors:  Miguel Hernandez Pampaloni; Uttam M Shrestha; Maria Sciammarella; Youngho Seo; Grant T Gullberg; Elias H Botvinick
Journal:  J Nucl Cardiol       Date:  2017-01-30       Impact factor: 5.952

3.  Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.

Authors:  Akhil Narang; John E Blair; Mita B Patel; Victor Mor-Avi; Savitri E Fedson; Nir Uriel; Roberto M Lang; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-04       Impact factor: 2.357

4.  Metabolism of nitrogen-13 labelled ammonia in different conditions in dogs, human volunteers and transplant patients.

Authors:  G Bormans; A Maes; W Langendries; J Nuyts; M Vrolix; J Vanhaecke; C Schiepers; M De Roo; L Mortelmans; A Verbruggen
Journal:  Eur J Nucl Med       Date:  1995-02

5.  Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac 82Rb PET.

Authors:  Uttam M Shrestha; Maria Sciammarella; Miguel Hernandez Pampaloni; Elias H Botvinick; Grant T Gullberg; Teresa DeMarco; Youngho Seo
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-29       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.